| For: | Ma YY, Leng Y, Xing YL, Li HM, Chen JB, Niu LZ. Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer. World J Clin Cases 2020; 8(22): 5564-5575 [PMID: 33344547 DOI: 10.12998/wjcc.v8.i22.5564] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i22/5564.htm |
| Number | Citing Articles |
| 1 |
Ricardo Azevedo, David Imagawa, Marianne Rara, Hannah Cho, Kellie Cho, Jennifer Valerin, Fa-Chyi Lee, Farshid Dayyani, Dayantha Fernando, Nadine Abi-Jaoudeh. Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. Journal of Vascular and Interventional Radiology 2026; 37(10) doi: 10.1016/j.jvir.2026.108954
|
| 2 |
Yangyang Ma, Yanli Xing, Hongmei Li, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Mao Lin, Lizhi Niu, Jinghua Pan. Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Journal of Oncology 2022; 2022 doi: 10.1155/2022/3523769
|
| 3 |
Andras Bibok, Dae Won Kim, Mokenge Malafa, Bela Kis. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer. World Journal of Gastroenterology 2021; 27(27): 4322-4341 doi: 10.3748/wjg.v27.i27.4322
|
| 4 |
Rasmus Virenfeldt Flak, Jonatan Riber Granborg, Christian Janfelt, Martin Skovmos Nielsen, Benedict Kjærgaard, Ole Thorlacius-Ussing. A characterization of the reversibly electroporated penumbra during irreversible electroporation. Cancer Treatment and Research Communications 2025; 45 doi: 10.1016/j.ctarc.2025.100985
|
| 5 |
Wenyuan Ma, Haoyu Liu, Fan Xu, Lei Xu, Chengyue Zhang, Wenjing Lou, Liting Xie, Tian’An Jiang. High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine. International Journal of Surgery 2026; 112(1) doi: 10.1097/JS9.0000000000003386
|
| 6 |
Florentine E F Timmer, Bart Geboers, Alette H Ruarus, Laurien G P H Vroomen, Evelien A C Schouten, Susan van der Lei, Danielle J W Vos, Madelon Dijkstra, Hannah H Schulz, Joyce Bakker, Bente A T van den Bemd, Petrousjka M van den Tol, Robbert S Puijk, Birgit I Lissenberg-Witte, Tanja D de Gruijl, Jan J J de Vries, Frank J Lagerwaard, Hester J Scheffer, Anna M E Bruynzeel, Martijn R Meijerink. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial. The Lancet Gastroenterology & Hepatology 2024; 9(5) doi: 10.1016/S2468-1253(24)00017-7
|
| 7 |
Yangyang Ma, Yanli Xing, Hongmei Li, Ting Yuan, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Shuying Li, Lizhi Niu. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1193040
|
| 8 |
Zainab L Rai, Veronica Ranieri, Daniel H Palmer, Peter Littler, Pauleh Ghaneh, Kurinchi Gurusamy, Derek Manas, Elena Pizzo, Eftychia Eirini Psarelli, Roopinder Gilmore, Praveen Peddu, David C Bartlett, Nicola de Liguori Carino, Brian R Davidson. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial. BMJ Open 2022; 12(5) doi: 10.1136/bmjopen-2021-050166
|
| 9 |
Cheng-Shien Shieh, Po-Long Cheng, I-Chun Lai, Wei-Yu Kao, Meng-Huang Wu, Jeng-Fong Chiou, Ping-Hsiu Wu, Hsin-Lun Lee. Survival benefit of particle chemoradiotherapy in locally advanced unresectable pancreatic cancer: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2026; 19 doi: 10.1177/17562848261465516
|
| 10 |
Agnieszka Gajewska-Naryniecka, Urszula Szwedowicz, Zofia Łapińska, Julia Rudno-Rudzińska, Wojciech Kielan, Julita Kulbacka. Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054381
|
| 11 |
Shahab Hajibandeh, Mariam Hussain, Kholoud Abu Taha, Vaishnavi Sujathan, Louise M. Finch, Shahin Hajibandeh, Vinotha Nadarajah, Jacob Kadamapuzha, Santhalingam Jegatheeswaran, Saurabh Jamdar, Panagiotis Stathakis, Rahul Deshpande, Ajith K. Siriwardena, Thomas Satyadas, Nicola de Liguori Carino. Survival After Irreversible Electroporation in Unresectable Locally Advanced Pancreatic Cancer: A Meta-analysis. Journal of Surgical Research 2026; 327 doi: 10.1016/j.jss.2026.08.030
|
| 12 |
Thomas Lambin, Cyril Lafon, Robert Andrew Drainville, Mathieu Pioche, Frédéric Prat. Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma. World Journal of Gastroenterology 2022; 28(13): 1288-1303 doi: 10.3748/wjg.v28.i13.1288
|
| 13 |
Liting Xie, Chengyue Zhang, Wenjing Lou, Fan Xu, Wenyuan Ma, Tian’an Jiang. Pulse Field Ablation in Oncology: Current Progress and Future Directions. Advanced Ultrasound in Diagnosis and Therapy 2025; 9(4) doi: 10.26599/AUDT.2025.250099
|
| 14 |
Robert C.G. Martin, Christopher D. Wilson. What Is the Role of Irreversible Electroporation for Pancreatic Cancer?. Advances in Surgery 2025; 59(1) doi: 10.1016/j.yasu.2025.04.011
|
| 15 |
Gabriel Marcellier, Theo Le Berre, Paul Rivallin, Marie Frenea-Robin, Frédéric Prat. Electroporation for the Treatment of Pancreatic Ductal Adenocarcinoma: A Systematic Review of Preclinical and Clinical Studies. Clinical and Translational Gastroenterology 2025; 16(11) doi: 10.14309/ctg.0000000000000911
|